Neuropeptide signals and specific neuropeptide receptors have been described in the thymus supporting the concept of a close dialogue between the neuroendocrine and the immune systems at the level of early T-cell differentiation. In this paper, we review recent data about neurohypophysial (NHP)-related peptides detected in the thymus from different species. We suggest that we are dealing in fact with other member(s) of the NHP hormone family, which seems to exert its activity locally through a novel model of cell-to-cell signaling, that of cryptocrine communication. This model involves exchange of signals between thymic epithelial cells and developing thymocytes. The NHP-related peptides have been shown to trigger thymocyte proliferation and could induce immune tolerance of this highly conserved neuroendocrine family.
INTRODUCTION
In the last decade, a number of studies has been reported indicating that various neuropeptides could be found in the thymus or in thymic neoplasms. Thus, neurotensin (NT) (Sundler et al., 1978 ; Herbst et al., 1987) , somatostatin (SS) (Sundler et al., 1978; Geppetti et al., 1987; Fuller and Verity, 1989; Gomariz et al., 1990) , oxytocin (OT) (Geenen et al., 1986; Ervin et al., 1988; Argiolas et al., 1990a; Jevremovic et al., 1990) , vasopressin (VP) (Markwick et al., 1986; Geenen et al., 1987; Giraud et al., 1990) , neurophysins (NPs) (Geenen et al., 1986) , tachykinins (TKs) (Geppetti et al., 1988; Weihe et al., 1989; Ericsson et al., 1990; Lorton et al., 1990; Piantelli et al., 1990) , neuropeptide Y (NPY) (D'Andrea et al., 1989; Weihe et al., 1989; Ericsson et al., 1990) , vasoactive intestinal peptide (VIP) (Felten et al., 1985; Gomariz et al., 1990; A1-Shawaf et al., 1991) , calcitonin gene-related peptide (CGRP) (Geppetti et al., 1989; Weihe et al., 1989) , opioid peptides (Von Gaudecker et al., 1986; Piantelli et al., 1990) , corticotropin (ACTH) (Her.bst et al., 1987) , cholecystokinin (CCK) (Herbst et al., 1987) , and atrial *Corresponding author. natriuretic peptide (ANP) (Vollmar and Schulz, 1990) have been immunologically, biologically, biochemically, and/or molecularly evidenced. These neuropeptides were not systematically located in the thymic structures. However, some immunoreactive (ir-) neuropeptides were localized in nerve fibers: substance P (SP) (Geppetti et al., 1987 (Geppetti et al., , 1988 Weihe et al., 1989; Lorton et al., 1990) , CGRP (Weihe et al., 1989) , VIP (Felten et al., 1985; A1-Shawaf et al., 1991) , NPY (D'Andrea et al., 1989; Weihe et al., 1989) . On the other hand, it was suggested that ANP could be localized in thymocytes (Vollmar and Schulz, 1990) . Furthermore, NT and SS immunoreactivities were found in sparse stromal cells (Sundler et al., 1978) , whereas neurokinin A (NKA) (Ericsson et al., 1990) , opioid peptides (Von Gaudecker et al., 1986; Piantelli et al., 1990) , OT, VP, and NPs (Robert et al., 1991) were localized in thymic epithelial cells (TEC) .
It is assumed that the action of neuropeptides is mediated through specific receptors on the target cells. The presence of such neuropeptide receptors in the thymus also was reported. Thus, binding sites for SP (Shigematsu et al., 1986) , ANP (Kurihara et al., 1987) , OT (Elands et al., 1988a) , and VP (Geenen et al., 1988b) have been reported. Thymic binding sites for SP were found associated with the vasculature in the medulla, where they may control blood flow and vascular permeability (Shigematsu et al., 1986) . On the other hand, specific binding sites for ANP were identified on the rat cortical and medullary thymocytes (Kurihara et al., 1987) . It was suggested that they could promote the proliferation and the maturation of thymocytes. Furthermore, it is likely that LH-RH and NKA binding sites are localized on thymocytes because they exert a mitogenic effect on these cells, although it is not excluded that this effect could be mediated by other cell types present in cell cultures (Marchetti et al., 1989; SOder and Hellstr6m, 1989 (Funder, 1990 (Acher and Chauvet, 1988 (Pavel, 1975; Smith and McIntosh, 1983; Ervin et al., 1985) as well as in the mammalian pineal gland (Pavel et al., 1975; Legros et al., 1976; Nieuwenhuis, 1984 (Acher and Chauvet, 1988) . Therefore, it has been assumed that the OT-like and the VP-like lineages arose from the duplication of one ancestral gene. Recent observations have further supported this postulated molecular mechanism (Morley et al., 1990) .
In mammals, the neurohormones of OT and VP are under the control of two independent genes expressed in magnocellular neurons of the hypothalamus. They are synthesized as large molecular weight precusors, which are then cleaved during axonal transpor t (Fig. 1) . Prooxyphysin (Pro-OT) is a 16-kD protein containing the OT sequence at its N-terminus, which is separated from the OT-associated neurophysin (OT-NP) by a Gly-Lys-Arg spacer sequence, and which contains an extra C-terminal amino acid (Land et al., 1983) . Propressophysin (Pro-VP) is a 20-kD glycoprotein that contains the VP sequence at the N-terminus separated from its associated NP by the same tripeptide spacer (Gly-Lys-Arg). In addition, Pro-VP contains a 39 amino acid terminal glycopeptide, the copeptin, which is separated from VP-NP by a single Arg spacer (Land et al., 1982) .
Neurophysins are small (93-95 residues) acidic proteins. The central part (residues 10-74), which is encoded by the second exon, is notably conserved during the evolutionary history of these peptides (Ivell and.Richter, 1984 (Michell et al., 1979) . Further, pharmacological studies using peptide binding assays have led to distinguish two V1 receptors subtypes named Via and VID (Jard et al., 1986 ).
OT receptors were described in the uterus, mammary gland, oviduct, and hippocampus. These receptors seem to be very closely related to the V1 type and also are coupled to phosphoinositide metabolism (Flint et al., 1986) .
EVIDENCE FOR NEUROHYPOPHYSIAL-LIKE PEPTIDES IN THYMIC EXTRACTS
We have previously demonstrated that ir-OT could be extracted by acetic acid from human thymuses as evidenced by specific radioimmunoassay (RIA) using antiserum AsO2 (Geenen et al., 1986 ). On isolated rat uterus, thymic extracts induced oxytocic contraction and the quantitative bioactivity was in agreement with the amounts detected by RIA. Ir-NPs also were detected in human thymic extracts using the antiserum A/5/IV. The molar ratio of ir-OT (2.2-18.4 ng/g) to ir-NPs (24-142 ng/g) was similar to that found in the hypothalamus (1:1), suggesting a local synthesis by cleavage from a common precursor. Ir-VP and ir-VP-NP also were detected in human thymic extracts (0.01-0.06 ng/g and 34-90 ng/g, respectively). The further finding of positive dot blot hybridizations of human thymic mRNA with bovine OT and VP cDNA probes constituted another argument for in situ synthesis, although this observation does not establish a conclusive demonstration of intrathymic OT and VP gene expression (Geenen et al., 1987) .
Thymic OT was further characterized by gel filtration on G-75 Sephadex: separate peaks of ir-OT and ir-NP were evidenced at the same positions as their respective reference preparations.
HPLC analysis of thymus extracts showed a single peak of ir-OT with a similar elution site as synthetic OT (Geenen et al., 1986 ).
Independently, ir-VP has been described in thymic extracts of rats and mice (Markwick et al., 1986) , and OT-, VP-ald VT-like peptides were reported in ovine thymus (Ervin et al., 1988) . The presence of ir-OT was recently confirmed in fetal human thymus (Jevremovic et al., 1990) and in rat thymus (Argiolas et al., 1990a) . The finding of a modulation of rat thymic ir-OT concentrations after diverse manipulations further supports a local intrathymic synthesis of an OT-like peptide (Argiolas et al., 1990b (Fig. 2C) . Several strains of mice (C3H, BALB/c, C57BL/Ka, CBA, SJL/J) as well as Wistar rats (Fig. 2D) exhibited the same pattern of reactivity. Moreover, the thymus of Brattleboro rats, which exhibit a deficit of the hypothalamic VP gene caused by a single deletion (Richter and Schmale, 1984) , also was stained by 033 (Fig. 2E) .
Using double immunofluorescence staining with A/5/III, a rabbit serum anti-NPs, we found that the same cells express together ir-OT and ir-NP (Robert et al., 1991 (Robert et al., 1991) .
Further, in human thymus, we showed that the stromal cells containing ir-neuropeptides corre-spond to a subset of epithelial cells expressing KL1-and KL4-defined cytokeratins (Robert et al., 1991) . The epithelial nature of the cells containing NHP-related peptides was confirmed, in rodent thymuses, using an antiserum to human keratins and KL4 (data not shown). However, KL1 only stained a few medullary TEC in rodents (Nicolas et al., 1989) , whereas it strongly labels cortical and medullary TEC from humans (Robert et al., 1991) , evidencing a certain disparity between rodent and human TEC.
Besides (Geenen et al., 1988a; Robert et al., 1991) , which recognizes the thymic neuroendocrine microenvironment producing the so-called thymic hormones (Haynes et al., 1983; Savino and Dardenne, 1984) . In human thymuses, we found that these TEC also contain some interleukin-1 (IL-lfl) immunoreactivity that was colocalized with ir-OT (Robert et al., 1991) . It is as well possible that they produce other lymphokines (interleukin-6, colony-stimulating factors, leukemia inhibitory factor) that were evidenced in culture supernatants of human TEC (Le et al., 1990 (Elands et al., 1990) . These receptors were detected in membrane preparations and on both mature and immature thymocytes, whereas VP receptors of the V1 type were identified on splenic lymphocytes. Using 3H-AVP and 3H-OT, we have found specific binding sites on RL12-NP, an immature T-cell line derived from a murine Xray-induced thymic lymphoma (Geenen et al., 1988b) , as well as on murine CTL-L, a cytotoxic T-cell line (Martens et Furthermore, the pharmacological characterization of thymic OT receptors is not selective enough to assume that the binding peptide is authentic OT, as it has been shown that OT recep-tors from the hippocampus, the uterus and the mammary gland does not discriminate between OT, VP, and VT Elands et al., 1988b) .
PHYSIOLOGICAL IMPLICATIONS
The physiological actions of OT-and VP-like peptides within the thymus remain to be further defined. They are not secreted in vitro (unpublished observation) and the classical model of neurosecretion is therefore questionable with regard to thymic epithelium-derived NHP signals. Rather, they seem implicated in thymic cell-to-cell interactions according to the novel "cryptocrine" model 1991b (Whitfield et al., 1970) and human (Martens et al., in press) thymocytes, as well as rat bt)ne marrow cells (Hunt et al., 1977) . On cultured fibroblasts, VP is considered to deliver an early regulatory signal of mitogenesis (Rozengurt, 1986) ; therefore, one can reasonably consider that thymic VP/OT-related peptide(s) provides accessory activation signals for thymocyte proliferation.
Ir-OT/VP are also detected in the medullary epithelium of thymus from different species and in cortical epithelium from rodent thymuses. Tolerogenic properties have been reported for murine TEC including TNC (Lorenz and Allen, 1989; Marrack et al., 1989; Webb and Sprent, 1990) , at least for some antigens (Ransom et al., 1991) . Obviously, the tolerance to OT seems particularly powerful and autoimmune processes have never been described against OT or OT-producing neurones. This is not the case for VP because some idiopathic dia.betes insipidus seem to be secondary to autoimmune "hypothalamitis" (Scherbaum and Bottazzo, 1983 
MATERIALS AND METHODS

Antibodies
The antioxytocin serum AsO2 was raised in rabbit against synthetic OT coupled to bovine thyroglobulin and was previously described (Geenen et al., 1985) . These antibodies react with OT: 100%, VT: 40%, and VP: 0.3%.
The rabbit serum against arginine-vasopressin used in RIA (AS2) was mainly directed to the C-terminal linear side chain of the VP molecule (Smitz et al., 1988) .
Rabbit antisera to bovine NPs (A/5/III, A/5/IV) were previously shown to recognize the central part of the molecule that is common to OT-NP and to VP-NP and is well conserved through mammals (Legros, 1975) .
To characterize VP-NP, we used a specific rabbit antiserum that did not recognize OT-NP, neither OT or VP (Legros and Ansseau, 1989) .
The characterization of Mabs to oxytocin was published in detail elsewhere (Burgeon et al., 1991 (Burgeon et al., 1991) . O13 and 022 belong to the IgG1 subclass, whereas 033 is an IgM.
The production and characterization of Mabs to vasopressin were previously reported (Robert et al., 1985 
